<DOC>
	<DOCNO>NCT00399074</DOCNO>
	<brief_summary>Malaria fatal increase risk death among child sickle cell anemia . Chemoprophylaxis significantly improve quality life child . In Uganda Chloroquine drug choice prophylaxis yet 's effectiveness limit due high level resistance throughout country . Intermittent presumptive treatment sulfadoxine - Pyrimethamine new approach malaria prevention , show great potential reduce incidence malaria anaemia among high risk group pregnant woman infant . However study do Uganda determine presumptive treatment sulfadoxine- pyrimethamine reduces incidence malaria child sickle cell anaemia . Hypothesis : Presumptive treatment sulfadoxine- Pyrimethamine well weekly chloroquine reduce incidence malaria child sickle cell anaemia .</brief_summary>
	<brief_title>Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine Malaria Prevention Children With Sickle Cell Anemia</brief_title>
	<detailed_description>Malaria fatal increase risk death among child sickle cell anemia . Chemoprophylaxis significantly improve quality life child . In Uganda Chloroquine drug choice prophylaxis yet 's effectiveness limit due high level resistance throughout country . Intermittent presumptive treatment sulfadoxine - pyrimethamine new approach malaria prevention , show great potential reduce incidence malaria anemia among high risk group pregnant woman infant . However study do Uganda determine presumptive treatment sulfadoxine- pyrimethamine reduces incidence malaria among high risk group child sickle cell anaemia . We calculate sample size 110 patient group power 95 % assume incidence malaria child receive weekly chloroquine 0.36 receive presumptive treatment sulfadoxine - pyrimethamine incidence would 0.16 accord ( schellenberg et al )</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<criteria>Children age 6 month 12 year attend sickle cell clinic Mulago Hospital study period negative peripheral smear parasite , adherence appointment visit , consent care taker participate study . Patients know allergy sulfonamide , Patients severe illness require urgent admission , Patients document treatment malaria past one month Sulfadoxine Pyrimethamine . Patients cotrimoxazole prophylaxis</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Sickle Cell anemia</keyword>
	<keyword>Malaria</keyword>
	<keyword>Presumptive treatment</keyword>
	<keyword>Sulfadoxine- pyrimethamine</keyword>
	<keyword>Children</keyword>
	<keyword>Uganda</keyword>
</DOC>